WATCH OUT FOR BERKSON'S BIAS (BB)! SETTING HEALTH-RELATED QUALITY OF LIFE (HRQOL) TREATMENT TARGETS WITH MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) IN ORDER TO PREDICT MATCHED GENERAL POPULATION CONTROL (MGPC) TARGETS, ASSESS POTENTIAL TO ...
Author(s)
Soini EJ1, Heinonen J2, Miettola E2, Ryynänen O3, Koskela T4
1ESIOR Oy, Kuopio, Finland, 2School of Medicine, University of Tampere, Finland, 3Faculty of Health Sciences, University of Eastern Finland, and Unit of Primary Health Care, Kuopio University Hospital, Kuopio, Finland, 4Department of General Practice, University of Tampere, and Omapihlaja, Pihlajalinna Terveys Oy, Tampere, Finland
OBJECTIVES: In BB-type selection bias all study groups include patients. BB can result to spurious associations and results in comparative settings. In HRQoL "burden comparisons", MGPC is often based on age and gender alone, if any. Furthermore, commonly available specialist care HRQoL data may generalize poorly to primary health care setting (PHCS) and may not include baseline values for patients entering the system. Thus, real-world evidence (RWE) generation for HRQoL benchmarking is difficult. Our objectives were to develop MAIC, predict MGPC based on the MAIC, estimate PTB and assess UMN; all at individual PHCS level. METHODS: A MAIC-based MGPC was developed using representative Finnish general population RWE (N ~5144) to estimate MGPC HRQoL ("reference value") for unselected patients participating in Effective Health Centre Study (N=511, three health centres, Pirkanmaa, Finland). Both studies used EQ-5D-3L with British preferences, and included age, sex, income, education, and comorbidities for the MAIC. PTB was estimated by subtracting the baseline EQ-5D-3L scores from the estimated MGPC scores. UMN (potential residual disutility) was estimated by subtracting the EQ-5D-3L scores at 3-month follow-up from the estimated MGPC scores. RESULTS: Mean baseline EQ-5D-3L scores for PHCS patients and MGPC were 0.74 and 0.81, respectively, demonstrating a significant and clinically important PTB (0.07; 95%CI 0.06-0.09), "medical need". Most patient groups demonstrated significant mean PTB. The mean PTB was highest for ICPC-2 chapter L: Musculoskeletal and lowest for S: Skin. The mean scores at three months for PHCS patients and MGPC were 0.79 and 0.81, respectively, demonstrating an insignificant UMN of 0.02 (95%CI 0.00-0.04). The mean UMN was highest among patients with ICPC-2 chapter N: Neurological or for patients with asthma comorbidity. The developed MAIC-based MGPC outperformed age- and sex-matched MGPC. CONCLUSIONS: BB and all time-specific measurements and their development can be taken into account in the MAIC-based MGPC, PTB and UMN HRQoL benchmarking.
Conference/Value in Health Info
2016-10, ISPOR Europe 2016, Vienna, Austria
Value in Health, Vol. 19, No. 7 (November 2016)
Code
PRM191
Topic
Methodological & Statistical Research, Study Approaches
Topic Subcategory
PRO & Related Methods
Disease
Multiple Diseases